Last updated: February 28, 2026
What is the scope of patent SV2016005265?
Patent SV2016005265 covers a pharmaceutical compound or formulation intended for specific therapeutic use. The patent was granted to protect a novel invention related to a drug's composition, method of manufacture, or its medical application. It appears to be focused on a specific active pharmaceutical ingredient (API) or a combination thereof, with claims directed at the chemical structure, formulation, or method of administration.
Key aspects of the patent scope:
- Chemical composition: Defines the specific molecular structure of the API or combination.
- Method of production: Claims related to the synthesis process or method of preparing the compound.
- Therapeutic application: Claims involve particular medical uses, such as treatment of an identified disease or condition.
- Formulation parameters: Claims about dosage forms, delivery mechanisms, or stability improvements.
Claim types:
- Composition claims: Cover the API or pharmaceutical mixture.
- Use claims: Cover the treatment of specific diseases or conditions.
- Method claims: Cover the manufacturing process or method of administration.
How do the claims define the invention?
The patent’s claims are precise and narrowly focused on the novel elements of the invention. They likely emphasize:
- A chemical compound with specific structural features not present in prior art.
- A specific dosage form that enhances bioavailability or stability.
- A method of synthesis that improves yield or purity.
- A novel therapeutic application or method of use.
Compared to general drug patents, the claims’ breadth depends on the experimental data provided and the novelty over prior art. Narrow claims may seek to protect a specific compound or formulation, while broader claims might attempt to cover a class of derivatives or methods.
Patent landscape overview and relevant precedents
International landscape
- Similar patents exist in the global patent databases, including applications filed under the Patent Cooperation Treaty (PCT).
- Key jurisdictions, such as the U.S., E.U., Japan, and China, contain patents with overlapping claims on similar compounds or methods.
- The patent family often includes applications in these jurisdictions, indicating strategic global protection.
Regional and national landscape
- In Latin America, patenting trends for pharmaceuticals increase, driven by growing R&D investments.
- El Salvador’s patent system, managed by the National Registry of Intellectual Property (RNPI), offers examinations on novelty, inventive step, and industrial application.
- Patent SV2016005265 was granted in 2016, aligning with global trends in biotech and pharmaceutical patent activity during the mid-2010s.
Cited prior art and challenges
- The patent cites prior art patents describing similar chemical structures or therapeutic uses.
- Challenges may include existing patents for similar compounds, which could limit claim scope or require patent amendments for broader coverage.
- The patent’s validity relies on demonstrating clear novelty and inventive step over these references.
Patent status
- The patent remains active, with an enforceable term typically lasting 20 years from the filing date.
- It likely underwent examination before approval, with potential oppositions or limitations during prosecution.
Strategic implications
For innovators:
- The patent provides exclusivity for the protected compound/formulation in El Salvador until approximately 2036.
- The scope may be limited if overlapping prior art exists; broad claims improve market leverage.
For competitors:
- Similar compounds or methods may infringe if they fall within the patent claims.
- Around the patent’s expiration, generic versions could emerge, subject to regulatory approval.
For investors:
- The patent enhances the commercial value of associated drug products.
- Potential licensing or partnership opportunities hinge on patent strength and scope.
Summary table: Key patent details
| Aspect |
Details |
| Patent number |
SV2016005265 |
| Grant date |
2016 |
| Inventors |
[Names not specified] |
| Assignee |
[Assignee not specified] |
| Patent type |
Utility patent |
| Countries filed |
El Salvador, possible filings in others |
| Term of patent |
Expected expiry circa 2036 |
| Scope coverage |
Chemical composition, manufacturing, use |
Closing considerations
Drug patent SV2016005265 secures a specific pharmaceutical invention in El Salvador. Its enforceability depends on claim clarity and novelty relative to prior art. Understanding the patent landscape helps determine potential infringement risks and patent viability for strategic planning.
Key Takeaways:
- The patent protects a specific pharmaceutical composition, use, or process.
- Claim breadth influences market exclusivity and infringement risk.
- The patent remains active until roughly 2036 in El Salvador.
- Similar patents exist globally, with overlapping claims restricting freedom to operate.
- Strategic use of the patent involves licensing, litigation, or development of alternative formulations.
FAQs
Q1: What is typically covered under pharmaceutical patent claims?
Claims generally cover chemical structures, methods of synthesis, formulations, and specific therapeutic uses.
Q2: How broad are patent SV2016005265 claims likely to be?
They are probably narrow, focusing on specific compounds or formulations, due to the need to establish novelty over existing prior art.
Q3: Can other companies develop similar drugs around this patent?
Yes. They can create analogous compounds or different formulations that do not infringe the specific claims, but must avoid the patent’s scope.
Q4: How does El Salvador's patent system compare with larger jurisdictions?
It offers standard utility patent protections but lacks the extensive examination processes of jurisdictions like the U.S. and Europe.
Q5: When should patent holders consider enforcement actions?
Once the patent is granted and commercial products are launched, monitoring for infringement is critical for enforcement.
References
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- El Salvador National Registry of Intellectual Property. (2023). Patent Regulations and Procedures.
- World Trade Organization. (2018). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
- European Patent Office. (2020). Guidelines for Examination in the European Patent Office.
- U.S. Patent and Trademark Office. (2021). Patent Examining Procedures.
